Zimmer Biomet (ZBH) PT Lowered to $175 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $99.57 +1.72%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Drew Ranieri lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $178.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
